CATION+ is officially a #nonprofit organization with a mission to advocate for Asian Americans in #nephrology across #NorthAmerica. Check out our new website https://t.co/JKHqDY3e61
Such an honor to welcome @rajmehrotra1122 from @UWNephrology to give the Fritz Port Lecture on “Improving the Lived Experience of Patients Undergoing Lon-Term Dialysis” for @UMIntMed grand rounds.
Just over 6 weeks until our 2024 Updates in Nephrology conference!
Featuring a group of fantastic speakers, relevant presentations, and in-person networking opportunities, this is a must-see event 👀
Register today at: https://t.co/Ai8ArOrJ4S
Our own @MonaDoshiMD was present at the signing of SB 384 by Governor Whitmer @gretchenwhitmer, prohibiting life, disability & long-term care insurers from refusing to insure, limiting coverage, or charging a different rate or premium based solely on living organ donor status.
Division of Nephrology @UMichKidney faculty, Drs. @LauraMarianiMD, @MonaDoshiMD & Julie Wright Nunes, speak on important current & proposed #KidneyDisease legislation to members of Congress on both the state & national levels.
Learn more: https://t.co/dgVBBbFmpy
Key to avoiding citrate tox is understanding citrate kinetics during CKRT. If endogenous clearance intact (no liver failure/severe shock), almost never an issue. But if suspect impaired endogenous clearance, protocol needs to be adjusted to increase filter citrate extraction.
Key to avoiding citrate tox is understanding citrate kinetics during CKRT. If endogenous clearance intact (no liver failure/severe shock), almost never an issue. But if suspect impaired endogenous clearance, protocol needs to be adjusted to increase filter citrate extraction.
Completely agree. Whether we call it citrate “toxicity”, “lock” or just “accumulation”, this is a real risk with citrate protocols. Most dangerous potential aspect to me is acute drop in pt iCa near initiation (ie. Initial bolus of citrate with poor endogenous clearance).
Completely agree. Whether we call it citrate “toxicity”, “lock” or just “accumulation”, this is a real risk with citrate protocols. Most dangerous potential aspect to me is acute drop in pt iCa near initiation (ie. Initial bolus of citrate with poor endogenous clearance).
Over the past year, AKINow's workgroups have worked to address the rising incidence of AKI through the development of educational content, outreach to the kidney community, and dissemination of best practice information https://t.co/tEJWXz2vyW
@renalgal
How it started: A little over 5yrs ago, I got to work w @ConnieMRhee, a great researcher and one of the nicest people ever.
How it’s going: Such and honor to share the @ASN stage at #KidneyWk with her yesterday to receive mid-career awards!
#AKINow team getting together at #KidneyWk 2023! Great work already done and much more ahead to improve AKI care worldwide, one step at the time @AsnEpc@ASNKidney
https://t.co/atlSQVYDEJ